1. Home
  2. WAFU vs SNGX Comparison

WAFU vs SNGX Comparison

Compare WAFU & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wah Fu Education Group Limited

WAFU

Wah Fu Education Group Limited

HOLD

Current Price

$1.57

Market Cap

6.7M

Sector

Real Estate

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.39

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAFU
SNGX
Founded
1999
1987
Country
China
United States
Employees
110
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
5.6M
IPO Year
2017
2006

Fundamental Metrics

Financial Performance
Metric
WAFU
SNGX
Price
$1.57
$0.39
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
24.4K
903.1K
Earning Date
07-31-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.03
EPS
N/A
N/A
Revenue
N/A
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.38
$0.28
52 Week High
$2.17
$6.23

Technical Indicators

Market Signals
Indicator
WAFU
SNGX
Relative Strength Index (RSI) 44.92 39.82
Support Level $1.52 $0.37
Resistance Level $1.74 $0.41
Average True Range (ATR) 0.08 0.02
MACD -0.01 0.01
Stochastic Oscillator 31.56 21.25

Price Performance

Historical Comparison
WAFU
SNGX

About WAFU Wah Fu Education Group Limited

Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

Share on Social Networks: